Apalutamid (neues Anwendungsgebiet, metastasiertes hormonsensitives Prostatakarzinom)

Grimm, Marc-Oliver, Kaiser, U., Wörmann, Bernhard, Miller, Kurt, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, Bokemeyer, Carsten, Cherny, Nathan I., Deutsche Gesellschaft Für Urologie, Heidenreich, Axel, Amsberg, Gunhild Von

Open source

DOI: 10.4126/frl01-006423073
Published: 2020
Container: Not recorded
Publisher: Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4126/frl01-006423073,
  title = {Apalutamid (neues Anwendungsgebiet, metastasiertes hormonsensitives Prostatakarzinom)},
  author = {Grimm, Marc-Oliver and Kaiser, U. and Wörmann, Bernhard and Miller, Kurt and Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie and Deutschland. Gemeinsamer Bundesausschuss and Bokemeyer, Carsten and Cherny, Nathan I. and Deutsche Gesellschaft Für Urologie and Heidenreich, Axel and Amsberg, Gunhild Von},
  year = {2020},
  doi = {10.4126/frl01-006423073},
  url = {https://doi.org/10.4126/frl01-006423073}
}

RIS

TY  - JOUR
TI  - Apalutamid (neues Anwendungsgebiet, metastasiertes hormonsensitives Prostatakarzinom)
AU  - Grimm, Marc-Oliver
AU  - Kaiser, U.
AU  - Wörmann, Bernhard
AU  - Miller, Kurt
AU  - Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie
AU  - Deutschland. Gemeinsamer Bundesausschuss
AU  - Bokemeyer, Carsten
AU  - Cherny, Nathan I.
AU  - Deutsche Gesellschaft Für Urologie
AU  - Heidenreich, Axel
AU  - Amsberg, Gunhild Von
PY  - 2020
DO  - 10.4126/frl01-006423073
UR  - https://doi.org/10.4126/frl01-006423073
ER  -

APA

Marc-Oliver, G., U., K., Bernhard, W., Kurt, M., Onkologie, D. G. F. H. U. M., Bundesausschuss, D. G., Carsten, B., I., C. N., Urologie, D. G. F., Axel, H., & Von, A. G. (2020). Apalutamid (neues Anwendungsgebiet, metastasiertes hormonsensitives Prostatakarzinom). https://doi.org/10.4126/frl01-006423073

Source records

datacite · retrieved 2026-09-27T06:58:37.604Z